Skip to content

Welcome to the 60th
EMWA Conference!

We are delighted to welcome you to the 60th EMWA Conference, taking place virtually this autumn. As we mark this milestone event, we invite you to join us online for a rich and flexible programme designed to support medical writers at every stage of their careers.
Booking is for EMWA members

Browse and fill a basket without an account. You must sign in as a member before you can check out.

«Back to the programme
WorkshopAdvancedPTA3c · 1 EPDP credits

PTA3c – Slippery Slopes:Survival Analysis

Tuesday 17 November 2026 · 13:30-17:00 CET · Thomas Schindler

Who it is for

The workshop is for everybody who has come into contact with the statistical technique of Kaplan-Meier survival analysis and who wants to know more about what it means. Ideally you should have encountered such analyses in the context of clinical trials.

What it covers

Some minimal statistical understanding is needed and terms like ‘median’, ‘mean’, ‘confidence interval’, ‘risk’ , and ‘p-value’ should not terrify you.
The workshop will give participants an understanding of the analysis of survival in the context of clinical trials. We will learn the basics of creating and interpreting Kaplan-Meier graphs and the different elements of reporting Kaplan-Meier analyses. The appropriate graphical and tabular presentation of these analyses will be discussed, but always the focus will be on the interpretation. There will be a few group exercises during the course.

Workshop leaders
Thomas Schindler

Thomas M Schindler studied biology and linguistics in Germany and the UK, obtained a PhD in molecular physiology, and did postdoctoral research in the UK. Thereafter, he became an editor of popular science books in biology, geography, and astronomy. He then turned to medical writing and has meanwhile gained some 30 years of experience in both medical communication and regulatory medical writing focussing on the preparation of clinical documents needed for marketing authorization applications in all relevant geographies across therapeutic areas. He founded and established the medical writing function at Boehringer Ingelheim Pharma and headed the Innovation Medical Writing Group focussing on lay communication, good graphics development, video creation and AI-driven writing at Boehringer Ingelheim Pharma. He was a member of the TransCelerate “Return of Results” work stream, is contributing to the Good Lay Summary Practice initiative and was co-author on PFMD Plain Language Summary guidance for scientific articles. Thereafter, he assumed the role of Director Global Regulatory Affairs in BioNTech serving as CTIS (Clinical Trial Information System) Lead supporting all aspects of clinical trial authorizations in EU and EEA. He has lately started his own consultancy “RSW – RegulatoryScienceWriting” providing support on medical writing and regulatory topics.

Back To Top
Your Cart

Your cart is empty.